Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 521 entries
View as:

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01054092 Org: User:
Start: 01/14/10 End: 07/22/11 Due: 07/22/12

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01242215 Org: User:
Start: 09/17/10 End: 04/25/12 Due: 04/25/13

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01225081 Org: User:
Start: 09/15/10 End: 04/28/12 Due: 04/28/13

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00411424 Org: User:
Start: 09/30/07 End: 06/30/09 Due: 06/30/10

Effect of Food Intake on Pharmacokinetic Profiles of Z-338

Phase: N/A Priority: Normal
NCT ID: NCT00920998 Org: User:
Start: 03/31/09 End: 06/30/09 Due: 06/30/10

A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

Phase: N/A Priority: Normal
NCT ID: NCT01534052 Org: User:
Start: 10/21/11 End: 04/18/17 Due: 04/18/18

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

Phase: N/A Priority: Normal
NCT ID: NCT04641962 Org: User:
Start: 05/24/21 End: 05/08/24 Due: 05/08/25

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00698243 Org: User:
Start: 06/30/08 End: 02/28/13 Due: 02/28/14

A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

Phase: N/A Priority: Normal
NCT ID: NCT01334918 Org: User:
Start: 04/26/11 End: 07/02/12 Due: 07/02/13

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00295607 Org: User:
Start: 06/30/05 End: 06/30/08 Due: 06/30/09

A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03070990 Org: User:
Start: 04/24/17 End: 02/25/19 Due: 02/25/20

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00257478 Org: User:
Start: - End: 03/31/07 Due: 03/31/08

A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00283946 Org: User:
Start: 02/28/06 End: 11/30/07 Due: 11/30/08

Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine

Phase: N/A Priority: Normal
NCT ID: NCT01964183 Org: User:
Start: 06/30/13 End: 08/31/13 Due: 08/31/14

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00535691 Org: User:
Start: 04/30/03 End: 12/31/04 Due: 12/31/05

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00189787 Org: User:
Start: - End: 08/31/05 Due: 08/31/06

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

Phase: N/A Priority: Normal
NCT ID: NCT00353678 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00046787 Org: User:
Start: 09/30/02 End: 02/28/03 Due: 02/28/04

Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT00047814 Org: User:
Start: 10/31/02 End: 03/31/06 Due: 03/31/07

Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01871987 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Phase 1 Study of OSI-930 in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00513851 Org: User:
Start: 04/30/06 End: 09/30/09 Due: 09/30/10

A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00965926 Org: User:
Start: 07/31/09 End: 09/30/09 Due: 09/30/10

YM443 in Subjects With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00102310 Org: User:
Start: 03/10/04 End: 03/11/06 Due: 03/11/07

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00282243 Org: User:
Start: 02/28/03 End: 10/31/08 Due: 10/31/09

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Phase: N/A Priority: Normal
NCT ID: NCT00106288 Org: User:
Start: 01/31/03 End: 12/31/05 Due: 12/31/06